Literature DB >> 33309333

Replication assessment of NUS1 variants in Parkinson's disease.

Bernabe I Bustos1, Sara Bandres-Ciga2, J Raphael Gibbs3, Dimitri Krainc4, Niccolo E Mencacci4, Ziv Gan-Or5, Steven J Lubbe6.   

Abstract

The NUS1 gene was recently associated with Parkinson's disease (PD) in the Chinese population. Here, as part of the International Parkinson's Disease Genomics Consortium, we have leveraged large-scale PD case-control cohorts to comprehensively assess damaging NUS1 variants in individuals of European descent. Burden analysis of rare nonsynonymous damaging variants across case-control individuals from whole-exome and -genome data sets did not find evidence of NUS1 association with PD. Overall, single-variant tests for rare (minor allele frequency<0.01) and common (minor allele frequency>0.01) variants, including 15 PD-GWAS cohorts and summary statistics from the largest PD GWAS meta-analysis to date, also did not uncover any associations. Our results indicate a lack of evidence for a role of rare damaging nonsynonymous NUS1 variants in PD in unrelated case-control cohorts of European descent, suggesting that the previously observed association could be driven by extremely rare population-specific variants.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  NUS1; Parkinson's disease; Rare-variant burden

Mesh:

Substances:

Year:  2020        PMID: 33309333      PMCID: PMC8958942          DOI: 10.1016/j.neurobiolaging.2020.11.007

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  6 in total

1.  Nogo-B receptor is necessary for cellular dolichol biosynthesis and protein N-glycosylation.

Authors:  Kenneth D Harrison; Eon Joo Park; Ningguo Gao; Andrew Kuo; Jeffrey S Rush; Charles J Waechter; Mark A Lehrman; William C Sessa
Journal:  EMBO J       Date:  2011-05-13       Impact factor: 11.598

2.  Coding mutations in NUS1 contribute to Parkinson's disease.

Authors:  Ji-Feng Guo; Lu Zhang; Kai Li; Jun-Pu Mei; Jin Xue; Jia Chen; Xia Tang; Lu Shen; Hong Jiang; Chao Chen; Hui Guo; Xue-Li Wu; Si-Long Sun; Qian Xu; Qi-Ying Sun; Piu Chan; Hui-Fang Shang; Tao Wang; Guo-Hua Zhao; Jing-Yu Liu; Xue-Feng Xie; Yi-Qi Jiang; Zhen-Hua Liu; Yu-Wen Zhao; Zuo-Bin Zhu; Jia-da Li; Zheng-Mao Hu; Xin-Xiang Yan; Xiao-Dong Fang; Guang-Hui Wang; Feng-Yu Zhang; Kun Xia; Chun-Yu Liu; Xiong-Wei Zhu; Zhen-Yu Yue; Shuai Cheng Li; Huai-Bin Cai; Zhuo-Hua Zhang; Ran-Hui Duan; Bei-Sha Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-22       Impact factor: 11.205

3.  Genetic analysis of NUS1 in Chinese patients with Parkinson's disease.

Authors:  Xiang Chen; Yousheng Xiao; Miaomiao Zhou; Yuwan Lin; Wenyuan Guo; Shuxuan Huang; Jiewen Qiu; Guoyou Peng; Mingshu Mo; Zhe Li; Xiaoqin Zhu; Pingyi Xu
Journal:  Neurobiol Aging       Date:  2019-09-10       Impact factor: 4.673

4.  Nogo-B receptor stabilizes Niemann-Pick type C2 protein and regulates intracellular cholesterol trafficking.

Authors:  Kenneth D Harrison; Robert Qing Miao; Carlos Fernandez-Hernándo; Yajaira Suárez; Alberto Dávalos; William C Sessa
Journal:  Cell Metab       Date:  2009-09       Impact factor: 27.287

5.  Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies.

Authors:  Mike A Nalls; Cornelis Blauwendraat; Costanza L Vallerga; Karl Heilbron; Sara Bandres-Ciga; Diana Chang; Manuela Tan; Demis A Kia; Alastair J Noyce; Angli Xue; Jose Bras; Emily Young; Rainer von Coelln; Javier Simón-Sánchez; Claudia Schulte; Manu Sharma; Lynne Krohn; Lasse Pihlstrøm; Ari Siitonen; Hirotaka Iwaki; Hampton Leonard; Faraz Faghri; J Raphael Gibbs; Dena G Hernandez; Sonja W Scholz; Juan A Botia; Maria Martinez; Jean-Christophe Corvol; Suzanne Lesage; Joseph Jankovic; Lisa M Shulman; Margaret Sutherland; Pentti Tienari; Kari Majamaa; Mathias Toft; Ole A Andreassen; Tushar Bangale; Alexis Brice; Jian Yang; Ziv Gan-Or; Thomas Gasser; Peter Heutink; Joshua M Shulman; Nicholas W Wood; David A Hinds; John A Hardy; Huw R Morris; Jacob Gratten; Peter M Visscher; Robert R Graham; Andrew B Singleton
Journal:  Lancet Neurol       Date:  2019-12       Impact factor: 44.182

6.  Establishing the role of rare coding variants in known Parkinson's disease risk loci.

Authors:  Iris E Jansen; J Raphael Gibbs; Mike A Nalls; T Ryan Price; Steven Lubbe; Jeroen van Rooij; André G Uitterlinden; Robert Kraaij; Nigel M Williams; Alexis Brice; John Hardy; Nicholas W Wood; Huw R Morris; Thomas Gasser; Andrew B Singleton; Peter Heutink; Manu Sharma
Journal:  Neurobiol Aging       Date:  2017-08-02       Impact factor: 4.673

  6 in total
  2 in total

Review 1.  Psychosis in Parkinson's Disease: A Lesson from Genetics.

Authors:  Efthalia Angelopoulou; Anastasia Bougea; Sokratis G Papageorgiou; Chiara Villa
Journal:  Genes (Basel)       Date:  2022-06-20       Impact factor: 4.141

2.  NUS1 and Epilepsy-myoclonus-ataxia Syndrome: An Under-recognized Entity?

Authors:  Giulietta M Riboldi; Edoardo Monfrini; Christine Stahl; Steven J Frucht
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2022-06-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.